Atlas Trials

A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function

Clinical trial NCT02665039 · COMPLETED

Trial details

NCT number
NCT02665039
Sponsor
Dr Anders Ullén
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Urothelial CarcinomaBladder CancerRenal Pelvis CancerUreter CancerUrethra Cancer
Start date
2014-04-01
Primary completion
2018-09-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.